Literature DB >> 26619376

Treatment with anti-cytokine monoclonal antibodies can potentiate the target cytokine rather than neutralize its activity.

C D Rudulier1, M Larché2, D Moldaver2.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 26619376     DOI: 10.1111/all.12816

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  6 in total

1.  Efficacy and safety of benralizumab in patients with eosinophilic asthma: a meta-analysis of randomized placebo-controlled trials.

Authors:  Ting Liu; Faping Wang; Geng Wang; Hui Mao
Journal:  Front Med       Date:  2017-10-30       Impact factor: 4.592

Review 2.  Overlapping Effects of New Monoclonal Antibodies for Severe Asthma.

Authors:  Christian Domingo
Journal:  Drugs       Date:  2017-10       Impact factor: 9.546

Review 3.  An Update on Lymphocyte Subtypes in Asthma and Airway Disease.

Authors:  Daniel M Moldaver; Mark Larché; Christopher D Rudulier
Journal:  Chest       Date:  2016-11-03       Impact factor: 9.410

4.  An Injectable Cytokine Trap for Local Treatment of Autoimmune Disease.

Authors:  Colin R Zamecnik; Elizabeth S Levy; Margaret M Lowe; Bahar Zirak; Michael D Rosenblum; Tejal A Desai
Journal:  Biomaterials       Date:  2019-11-12       Impact factor: 12.479

Review 5.  dIvergEnt: How IgE Axis Contributes to the Continuum of Allergic Asthma and Anti-IgE Therapies.

Authors:  Óscar Palomares; Silvia Sánchez-Ramón; Ignacio Dávila; Luis Prieto; Luis Pérez de Llano; Marta Lleonart; Christian Domingo; Antonio Nieto
Journal:  Int J Mol Sci       Date:  2017-06-21       Impact factor: 5.923

Review 6.  Blood Eosinophils as Biomarkers to Drive Treatment Choices in Asthma and COPD.

Authors:  Konstantinos Kostikas; Caterina Brindicci; Francesco Patalano
Journal:  Curr Drug Targets       Date:  2018       Impact factor: 3.465

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.